Equinox vs Uncommon Therapeutics

Side-by-side comparison of AI visibility scores, market position, and capabilities

Equinox leads in AI visibility (74 vs 27)

Equinox

LeaderFitness & Wellness

Luxury Gym

Luxury fitness club with $300+/month membership; 110 locations with spa amenities, SoulCycle and Equinox Hotels portfolio, targeting premium urban professionals.

AI VisibilityBeta
Overall Score
B74
Category Rank
#1 of 1
AI Consensus
64%
Trend
stable
Per Platform
ChatGPT
68
Perplexity
83
Gemini
74

About

Equinox is a luxury fitness club brand operating premium health clubs in major metropolitan areas across the United States, with flagship locations known for exceptional facilities, high-end amenities, and a curated fitness culture that commands premium membership fees of $300+ per month. Founded in 1991 in New York City and expanding to approximately 110 locations, Equinox Holdings also owns SoulCycle (indoor cycling studios), Blink Fitness (budget clubs), and the Equinox Hotels brand — creating a portfolio spanning the entire fitness market spectrum.

Full profile

Uncommon Therapeutics

EmergingHealthcare

General

Rare disease biotech developing polytherapy approach for Rett Syndrome (1 in 10,000 girls); founder-developed protocol validated through personal patient experience competing with Acadia Pharmaceuticals Daybue in Rett market.

AI VisibilityBeta
Overall Score
D27
Category Rank
#1121 of 1167
AI Consensus
67%
Trend
stable
Per Platform
ChatGPT
28
Perplexity
33
Gemini
36

About

Uncommon Therapeutics is a biotech company founded by Noah Auerhahn — directly inspired by his daughter's diagnosis with Rett Syndrome, a severe genetic neurological disease affecting approximately 1 in 10,000 girls — applying a polytherapy approach (combining multiple therapeutic agents targeting different disease mechanisms simultaneously) to develop treatments for serious neurological and rare diseases. After improving his daughter's quality of life through a personally developed polytherapy protocol, Auerhahn founded Uncommon Therapeutics to translate these insights into pharmaceutical products for the broader Rett Syndrome patient community.

Full profile

AI Visibility Head-to-Head

74
Overall Score
27
#1
Category Rank
#1121
64
AI Consensus
67
stable
Trend
stable
68
ChatGPT
28
83
Perplexity
33
74
Gemini
36
70
Claude
22
70
Grok
33

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.